| Literature DB >> 26730437 |
Masakazu Nakadai1, Shuta Tomida2, Kazuhisa Sekimizu1,3.
Abstract
Druggable sites on protein-protein interfaces are difficult to predict. To survey inhibitor-binding sites onto which residues are superimposed at protein-protein interfaces, we analyzed publicly available information for 39 inhibitors that target the protein-protein interfaces of 8 drug targets. By focusing on the differences between residues that were superimposed with inhibitors and non-superimposed residues, we observed clear differences in the distances and changes in the solvent-accessible surface areas (∆SASA). Based on the observation that two or more residues were superimposed onto inhibitors in 37 (95%) of 39 protein-inhibitor complexes, we focused on the two-residue relationships. Application of a cross-validation procedure confirmed a linear negative correlation between the absolute value of the dihedral angle and the sum of the ∆SASAs of the residues. Finally, we applied the regression equation of this correlation to four inhibitors that bind to new sites not bound by the 39 inhibitors as well as additional inhibitors of different targets. Our results shed light on the two-residue correlation between the absolute value of the dihedral angle and the sum of the ∆SASA, which may be a useful relationship for identifying the key two-residues as potential targets of protein-protein interfaces.Entities:
Mesh:
Substances:
Year: 2016 PMID: 26730437 PMCID: PMC4698585 DOI: 10.1038/srep18543
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Eight target-partner proteins, 39 inhibitors, and 64 selected residues.
| Target protein/partner protein | PDB IDs of protein-protein complexes | PDB IDs of protein-inhibitor complexes | Selected residues (n = 64) | |
|---|---|---|---|---|
| superimposed residues (n = 26) | non-superimposed residues (n = 38) | |||
| BCL-xL/Bim | 1PQ1 | 1YSI, 3ZLN, 2YXJ, 3ZLR, 3SP7 | A91, L94, I97, D99, F101, Y105 | R85, P86, R89, I90, R95, R108 |
| Integrase/LEDGFp75 | 2B4J | 3LPT, 3LPU, 3ZSO, 4LH5, 4ELM, 4E1N | I365, D366, L368 | K360, K364, F406, V408 |
| Mcl/Bim BH3 | 2NL9 | 4HW2, 3WIX | L62 | E55, I58, A59, R63, I65, D67, F69, Y73 |
| Menin/MLL | 4GQ6 | 4GQ3, 4OG4, 4OG3 | F9, P10, P13 | A5, R6, W7, R8, A11, R12 |
| Mdm/p53 | 1YCR | 4JV9, 4JVE, 4J7D, 4J7E, 4IPF, 1RV1, 1T4E, 3JZK, 3LBK, 3LBL, 4ERE, 2LZG | F19, W23, L26 | E17, L22, P27, E28, |
| XIAP-BIR3/Caspase 9 | 1NW9 | 1TFQ, 1TFT | A316, T317, P318, F319 | L244, L385, C403, F406, K410 |
| XIAP-BIR3/Smac | 1G73 | 3EYL, 2OPY, 4HY0, 4KJV, 3GTA, 3F7I | A1, V2, P3, I4 | — |
| ZipA/Fits | 1F47 | 1S1S, 1Y2F, 1Y2G | F11, L12 | D4, Y5, L6, D7, I8 |
aThere were no non-superimposed residues in XIAP-BIR3/Smac.
Figure 1(a) Example of a protein-protein structure (pdb:1YCR) and protein-inhibitor structure (pdb:1RV1). (b) Example of computational alignment. The alignment between Mdm of the protein–protein complex (pdb:1YCR, green) and Mdm of the inhibitor–protein complex (pdb: 1RV1, purple) is shown. (c) The numerical distribution of residues that were superimposed onto an inhibitor. (d) Example of a method of measuring the structural data of the residue pairs. The distances of Cα – Cα and Cω – Cω were measured. The Cω – Cα – Cα – Cω dihedral angles of the residues are shown (pdb:1YCR). The structural figure was generated using PyMOL (http://www.pymol.org).
Difference between the superimposed residuesa (n = 26) and non-superimposed residuesb (n = 38).
| all residues (n = 64) | superimposed residues | non-superimposed residues | ||
|---|---|---|---|---|
| Secondary structures | number | number | number | |
| α-Helix | 34 | 12 | 22 | |
| β-turn | 9 | 4 | 5 | |
| loop | 21 | 10 | 11 | |
| Descriptors | ΔG | −3.5 (−3.0) 2.5 | −3.6 (−3.1) 2.2 | −3.5 (−2.6) 2.8 |
| HE [kcal/mol] | 2.9 (3.1) 0.9 | 3.2 (3.5) 0.9 | 2.7 (2.3) 0.9 | |
| ΔSASA [Å2 ] | 71.8 (73.4) 34.5 | 85.4 (86.2) 33.1 | 61.9 (62.5) 32.5 |
aResidues that were superimposed onto the inhibitors.
bResidues that were not superimposed onto the inhibitors.
cNumber of secondary structures to which the residues belonged.
dLoop or strand.
Comparison among the superimposed residue pairsa, non-superimposed residue pairsb, and superimposed residue-non-superimposed residue pairs .
| All residue pairs (n = 243) | Superimposed residue pairs (SIRPs) | nonSIR-nonSIR | SIR-nonSIR | |
|---|---|---|---|---|
| Mean (median) SD | Mean (median) SD | Mean (median) SD | Mean (median) SD | |
| distance (Cω- Cω) [Å] | 13.3 (11.9) 6.4 | 9.3 (8.7) 3.9 | 13.7 (12.7) 6.7 | 14.3 (13.1) 6.3 |
| distance (Cα – Cα) [Å] | 11.4 (10.1) 6.5 | 7.6 (6.9) 4.0 | 11.0 (9.9) 6.8 | 12.7(12.1) 6.8 |
| ∑ΔSASA [Å 2] | 141.8 (141.0) 48.2 | 167.8 (170.8) 42.8 | 130.5 (125.5) 47.1 | 143.3 (145.9) 47.1 |
| ∑ΔG | −6.9 (−6.2) 3.5 | −7.2 (−6.5) 3.0 | −7.3 (−6.2) 4.1 | −6.4 (−5.9) 2.9 |
| ∑HE [kcal/mol] | 5.8 (5.7) 1.2 | 6.2 (6.3) 1.1 | 5.4 (5.3) 1.2 | 6.0 (5.8) 1.2 |
| DA [degree] | −13.7 (−14.1) 93.7 | −18.1 (−22.7) 90.2 | −19.0 (−15.7) 97.9 | −9.5(−6.3) 92.0 |
| |DA| [degree] | 79.6 (70.8) 51.3 | 76.8 (71.3) 51.0 | 83.3 (84.0) 54.9 | 78.0 (75.8) 46.2 |
aPairs of residues that were superimposed onto the inhibitors.
bPairs of residues that were not superimposed onto the inhibitors.
cPairs that one residue was superimposed onto an inhibitor and another was not superimposed onto inhibitors.
Figure 2Correlations of the dihedral angles of the residues that were superimposed onto the inhibitors.
(a) Correlation between DA and ∑∆SASA (DA>0 (n = 12, ◇) and DA<0 (n = 23, △)). (b) Correlation between |DA| and ∑∆SASA (n = 35, ○). (c) All 243 residue pairs (n = 243, +) were plotted on the graph (|DA| (x-axis) and ∑∆SASA (y-axis)).
Figure 3Application of the correlation between |DA| and ∑∆SASA (n = 35) (0).
(a) The application of the correlation to 4 inhibitors that bind to new sites not bound by the 39 inhibitors(these 4 inhibitors bind to 3 of the 8 targets). Seven new SIRPs (●) are plotted in Fig. 2b. (b) LOOCV results using 42 samples (c) The application of the correlation to two novel targets (Keap1-Nrf2 and VHL-HIF1) and another MDM2 inhibitor,. 10 SIRPs (●) are plotted using the regression equation shown in Fig. 3b.
Figure 4Scheme summarizing the application of our results.